Emerald - About the company
Emerald is a seed company based in London (United Kingdom), founded in 2024 by Dan Mcnally, Alexander Badalyan and Anton Shchipanov. It operates as a Provider of biannual biomarker testing, GP review, and health insights. Emerald has raised $2.97M in funding from Boost Capital Partners. The company has 18 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Thriva, Klarity and Anja.
Company Details
Provider of biannual biomarker testing, GP review, and health insights. It offer comprehensive health assessments through lab visits and analysis. Results are verified and explained by certified GPs, with personalized action plans. The service includes continuous access to a private GP for preventative care. It allows users to track biomarker enhance over time and receive GP referral letters.
- Website
- withemerald.com
- Registered Address
- 71-75 SHELTON STREET, COVENT GARDEN, LONDON, UNITED KINGDOM, WC2H 9JQ
Key Metrics
Founded Year
2024
Location
London, United Kingdom
Stage
Seed
Total Funding
$2.97M in 4 rounds
Latest Funding Round
Investors
Ranked
1st among 18 active competitors
Employee Count
25 as on Sep 30, 2026
Legal entities associated with Emerald
Emerald is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
EMERALD LABS LTD CIN: 15776578 , United Kingdom, Active | Jun 13, 2024 | - | - |
Sign up to download Emerald's company profile
Emerald's funding and investors
Emerald has raised a total funding of $2.97M over 4 rounds. Its first funding round was on May 30, 2025. Its latest funding round was a Seed round on Oct 20, 2026 for $*****. 3 investors participated in its latest round. Emerald has 5 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Emerald:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 20, 2026 | 9102434 | Seed | 6490249 | 4098392 | 5904624 | 1562413 |
Oct 20, 2026 | 6764701 | Grant (prize money) | 6973807 | 2361082 | 1342210 | |
Jan 29, 2026 | 8008529 | Seed | 5776797 | 6948065 |
View details of Emerald's funding rounds and investors
Emerald's founders and board of directors
Founder? Claim ProfileThe founders of Emerald are Dan Mcnally, Alexander Badalyan and Anton Shchipanov. Alexander Badalyan is the CEO of Emerald.
Here are the details of Emerald's key team members:
- Dan Mcnally: Co-Founder of Emerald. Contact Info: 1 email address
- Alexander Badalyan: Co-Founder & CEO of Emerald. Contact Info: 1 email address
- Anton Shchipanov: Co-Founder & CTO of Emerald. Contact Info: 1 email address
Emerald's Board of Directors
Emerald's board has 1 active member. Alexander Badalyan is part of team.Here is the list of Emerald's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 2y 4m |
View details of Emerald's Founder profiles and Board Members
Emerald's employee count trend
Emerald has 25 employees as of Sep 26. Here is Emerald's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Emerald's Competitors and alternates
Top competitors of Emerald include Thriva, Klarity and Anja. Here is the list of Top 10 competitors of Emerald, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Emerald 2024, London (United Kingdom), Seed | Provider of biannual biomarker testing, GP review, and health insights | $2.97M | 57/100 | |
2nd | Thriva 2015, London (United Kingdom), Series A | Provider of at-home blood tests | $17.1M | 50/100 | |
3rd | Klarity 2016, Bournemouth (United Kingdom), Unfunded | Provider of a platform for a home-based blood test and medical data management | - | - | 45/100 |
4th | Anja 2021, Los Angeles (United States), Seed | Provider of cord blood test kits | $5M | 42/100 | |
5th | Ivie Wellness 2022, Nuneaton (United Kingdom), Unfunded | Provider of at home health testing kits and health checks | - | - | 36/100 |
6th | Medichecks 2001, Nottingham (United Kingdom), Funding Raised | Online platform for home-to-lab Dx tests | - | 33/100 | |
7th | Flebo 2023, London (United Kingdom), Unfunded | Provider of home-based blood testing and comprehensive health tracking services | - | - | 30/100 |
8th | Goodbody Health 2011, Frome (United Kingdom), Public | Distributor and retailer of generic drugs | - | - | 24/100 |
9th | Zest 2006, Sheffield (United Kingdom), Unfunded | Provider of at-home functional age test kits and personalized health plans | - | - | 24/100 |
10th | Tigeni 2018, London (United Kingdom), Funding Raised | Provider of home-based blood test | - | 23/100 |
Looking for more details on Emerald's competitors? Click here to see the top ones
Emerald's Investments and acquisitions
Emerald has made no investments or acquisitions yet.
Reports related to Emerald
Here is the latest report on Emerald's sector:
News related to Emerald
Media has covered Emerald for a total of 2 events in the last 1 year, 1 of them has been about company updates.
•
The Best 5 Preventive Health Screening Services in the UK for Catching Problems EarlyDaily Business•Apr 23, 2026•Emerald, Bupa, Randox, Nuffield Health
•
Emerald closes $2M pre-seed to blend blood testing, AI, and medical careTech Funding News•Jan 29, 2026•Emerald, Boost Capital Partners, Granatus Ventures
•
Are you a Founder ?
FAQs about Emerald
Explore our recently published companies
- Shairart - Braga based, 2014 founded, Unfunded company
- Searchscope - Unfunded company
- Ellipsus - Berlin based, 2022 founded, Funding Raised company
- Tech Insights Hub - Unfunded company
- Talvi - United Kingdom based, 2025 founded, Unfunded company
- OLYTECH Design - Abuja based, 2023 founded, Unfunded company
